Telaglenastat Uses, Dosage, Side Effects and more
Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
| Trade Name | Telaglenastat |
| Generic | Telaglenastat |
| Telaglenastat Other Names | Telaglenastat |
| Type | |
| Formula | C26H24F3N7O3S |
| Weight | Average: 571.58 Monoisotopic: 571.161343324 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
